Journal article

Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis

Premika SW Boedhoe, Lianne Schmaal, Yoshinari Abe, Stephanie H Ameis, Paul D Arnold, Marcelo C Batistuzzo, Francesco Benedetti, Jan C Beucke, Irene Bollettini, Anushree Bose, Silvia Brem, Anna Calvo, Yuqi Cheng, Kang Ik K Cho, Sara Dallaspezia, Damiaan Denys, Kate D Fitzgerald, Jean-Paul Fouche, Monica Gimenez, Patricia Gruner Show all

American Journal of Psychiatry | AMER PSYCHIATRIC PUBLISHING, INC | Published : 2017

Grants

Awarded by NIH BD2K


Awarded by Hartmann Muller Foundation


Awarded by Deutsche Forschungsgemeinschaft


Awarded by Marato TV3 Foundation


Awarded by South London and Maudsley Trust, London


Awarded by Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT KAKENHI)


Awarded by Government of India of the Department of Science and Technology


Awarded by Government of India of the Department of Biotechnology


Awarded by Wellcome-DBT India Alliance grant


Awarded by Carlos III Health Institute


Awarded by FEDER funds/European Regional Development Fund, AGAUR


Awarded by "Miguel Server" contract from the Carlos III Health Institute


Awarded by Italian Ministry of Health


Awarded by Swiss National Science Foundation


Awarded by Netherlands Organization for Scientific Research


Awarded by Grants-in-Aid for Scientific Research


Awarded by NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES


Awarded by NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING


Awarded by NATIONAL INSTITUTE OF MENTAL HEALTH


Funding Acknowledgements

The ENIGMA OCD Working Group gratefully acknowledges support from the NIH BD2K award U54 EB020403-02 (principal investigator, Dr. Thompson). Supported by the Neuroscience Campus Amsterdam, IPB-grant to Dr. Schmaal and Dr. van den Heuvel; the Hartmann Muller Foundation (No. 1460 to Dr. Brem); the International Obsessive-Compulsive Disorder Foundation Research Award to Dr. Gruner; the Deutsche Forschungsgemeinschaft (KO 3744/2-1 to Dr. Koch); the Marato TV3 Foundation grants 01/2010 and 091710 to Dr. Lazaro; the Wellcome Trust and a pump priming grant from the South London and Maudsley Trust, London (project grant no. 064846) to Dr. Mataix-Cols; the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT KAKENHI No. 26461753 to Dr. Nakamae); Government of India grants to Prof. Reddy (SR/S0/HS/0016/2011) and Dr. Narayanaswamy (DST INSPIRE faculty grant -IFA12-LSBM-26) of the Department of Science and Technology; the Government of India grants to Prof. Reddy (No.BT/PR13334/Med/30/259/2009) and Dr. Narayanaswamy (BT/06/IYBA/2012) of the Department of Biotechnology; the Wellcome-DBT India Alliance grant to Dr. Venkatasubramanian (500236/Z/11/Z); the Carlos III Health Institute (CP10/00604, PI13/00918, PI13/01958, PI14/00413/PI040829); FEDER funds/European Regional Development Fund, AGAUR (2014 SGR 1672 and 2014 SGR 489); a "Miguel Server" contract (CP10/00604) from the Carlos III Health Institute to Dr. Soriano-Mas; the Italian Ministry of Health (RC10-11-12-13-14-15A to Dr. Spalletta); the Swiss National Science Foundation (No. 320030_130237 to Dr. Walitza); and the Netherlands Organization for Scientific Research (NWO VIDI 917-15-318 to Dr. van Wingen).Dr. Menchon has received grants and served as consultant, adviser, or speaker for AB-Biotics, Ferrer, GlaxoSmithKline, Janssen, Lundbeck, Medtronic, Otsuka, and the Spanish Ministry of Science and Innovation (CIBERSAM). Dr. Minuzzi has received grant or research support from the Alternative Funding Plan Innovation Fund, the Brain and Behavioral Foundation, the Canadian Institutes of Health Research, the Hamilton Health Sciences Foundation, the Ontario Brain Institute, and the Ontario Mental Health Foundation; he has served as a consultant or speaker for Bristol-Myers Squibb, the Canadian Psychiatric Association, the Canadian Network for Mood and Anxiety Treatments, and Lundbeck. Dr. Simpson receives royalties from Cambridge University Press and UpToDate. Prof. Dr. Walitza has received lecture honoraria from Opopharma and Eli Lilly; her work and research have been partially supported by the Swiss National Science Foundation, the German Research Foundation, Hochspezialisierte Medizin of the Canton of Zurich, and the German Federal Ministry of Education and Research. Dr. Stein has received research grants or consultancy honoraria from AMBRF, Biocodex, Cipla, Lundbeck, the National Responsible Gambling Foundation, Novartis, Servier, and Sun. Dr. van den Heuvel has received research funding (sponsor-initiated clinical trial) from PhotoPharmics and has served as a speaker for Lundbeck. The other authors report no financial relationships with commercial interests.